Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...

When I began Ozempic, in April 2023, I was in the doldrums of perimenopause, with high cholesterol, prediabetic blood sugar ...

Vitamin D also helps clear beta amyloid, a protein that plays a role in Alzheimer’s disease, Merrill points out. This is “the ...

State Sen. Catherine Blakespear wants to engage stakeholder groups to discuss possible changes to the law, but she faces ...

This University of Waterloo study shows how antipsychotic medications significantly worsened behavior in nursing home ...

lipid-lowering drug, OAC, and/or renin–angiotensin system (RAS)–acting agent use since 2005. Long-term use was defined as 5 years or longer. In total, there were 88,065 dementia diagnosis ...

Alzheimer's disease affects memory, thinking and behaviour, and while age stands as the predominantly known risk factor, your lifestyle choices can also sway the odds. An enlightening article ...

Antibiotics don’t appear to increase the risk of cognitive decline or dementia in older adults ... these findings offer reassurance about using these medications,” senior researcher Dr. Andrew Chan, a ...

While there are medications that can help diminish some ... Watching the wrecking ball of Lewy body dementia careen into the fortress of my father’s mind has been devastating.